Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -11.28%-93.22K | -42,852.97%-316.37K | -231.29%-24.34K | 68.58%-132.18K | 40.22%-41.8K | -83.77K | 100.83%740 | 97.20%-7.35K | -4.45%-420.68K | -581.99%-69.92K |
| Net income from continuing operations | -6.68%-80.44K | -461.69%-455.36K | -19.95%-55.07K | 4.55%-301.25K | -28.74%-98.87K | ---75.4K | 22.47%-81.07K | 65.80%-45.91K | 86.07%-315.61K | 65.64%-76.8K |
| Operating gains losses | ---- | ---- | ---- | 29.11%-55.36K | ---- | ---- | ---- | ---- | -250.53%-78.1K | ---- |
| Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Remuneration paid in stock | --0 | --0 | --0 | -46.12%19.86K | 108.65%1.65K | --3.29K | -85.53%5.68K | -44.46%9.25K | -75.98%36.87K | -136.31%-19.02K |
| Other non cashItems | ---11.22K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | 86.64%-1.56K | -103.60%-2.74K | 4.83%30.73K | 420.45%204.57K | 6.53%110.79K | ---11.66K | 423.90%76.13K | 120.31%29.31K | -107.06%-63.84K | -91.50%104K |
| -Change in receivables | 68.85%-2.23K | -769.18%-5.53K | 31.83%-938 | 109.42%1.18K | 822.48%10.34K | ---7.15K | 91.09%-636 | 78.99%-1.38K | ---12.57K | --1.12K |
| -Change in prepaid assets | --0 | --0 | --0 | 220.74%4.93K | --0 | --0 | 158.48%2.46K | 191.13%2.46K | -363.16%-4.08K | -122.98%-715 |
| -Change in payables and accrued expense | 114.78%668 | -96.24%2.79K | 12.19%31.67K | 520.54%198.46K | -3.04%100.45K | ---4.52K | 711.32%74.31K | 120.36%28.23K | -105.23%-47.19K | -91.51%103.6K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -11.28%-93.22K | -42,852.97%-316.37K | -231.29%-24.34K | 68.58%-132.18K | 40.22%-41.8K | ---83.77K | 100.83%740 | 97.20%-7.35K | -4.45%-420.68K | -581.99%-69.92K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | |||||||||
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 81.42%84.36K | 584.44%308K | 40K | -69.08%131.5K | 40K | 46.5K | 45K | 0 | 32.89%425.28K | 0 |
| Net issuance payments of debt | --0 | --37K | --40K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net common stock issuance | 132.26%108K | ---- | ---- | -73.70%131.5K | --40K | --46.5K | --45K | --0 | 31.93%500K | --0 |
| Net other financing activities | ---23.64K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -26.67%-74.72K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 81.42%84.36K | 584.44%308K | --40K | -69.08%131.5K | --40K | --46.5K | --45K | --0 | 32.89%425.28K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -68.23%14.8K | 2,648.75%23.17K | -8.28%7.51K | 128.07%8.19K | -88.08%9.31K | -40.36%46.58K | -99.50%843 | 128.07%8.19K | -95.90%3.59K | 464.24%78.11K |
| Current changes in cash | 76.23%-8.86K | -118.30%-8.37K | 313.15%15.66K | -114.74%-678 | 97.43%-1.8K | ---37.27K | 151.49%45.74K | -104.50%-7.35K | 105.48%4.6K | -581.99%-69.92K |
| End cash Position | -36.19%5.94K | -68.23%14.8K | 2,648.75%23.17K | -8.28%7.51K | -8.28%7.51K | -88.08%9.31K | -40.36%46.58K | -99.50%843 | 128.07%8.19K | 128.07%8.19K |
| Free cash from | -11.28%-93.22K | -42,852.97%-316.37K | -231.29%-24.34K | 68.58%-132.18K | 40.22%-41.8K | ---83.77K | 100.83%740 | 97.20%-7.35K | -4.15%-420.68K | -581.99%-69.92K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.